Tnase MA, Raducan A, Oancea P, Diu LM, Stan M, Petcu C, et al
Our team recommends batch purchasing only after completing an initial eight-week trial to confirm tolerance and response before committing to long-term supply
Serious adverse events are less common but documented: pancreatitis, gallbladder disease, hypoglycemia (particularly in patients on concomitant diabetes medications), and a boxed warning regarding medullary thyroid carcinoma risk in rodent studies - a finding whose clinical significance in humans at therapeutic doses remains under study
Pazos F, Snchez-Franco F, Balsa J, et al
Moreover, a greater proportion of participants on retatrutide 8 and 12 mg (7782%) achieved an HbA1c 6.5% compared to placebo (5%) and dulaglutide 1.5 mg (43%)
What Does the Clinical Research Actually Show